Exposure to halogenated ethers causes neurodegeneration and behavioural changes in young healthy experimental

Carlijn R Hooijmans1, Marije Buijs2, Frederique Struijs2

  • 1Department of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Geert Grooteplein-Noord 21, route 126, 6525 GA, Nijmegen, The Netherlands. carlijn.hooijmans@radboudumc.nl.

Scientific Reports
|May 18, 2023
PubMed

Insights

Inhalational anesthetics like sevoflurane and isoflurane can harm young children's brains, causing neurodegeneration and behavioral issues even after one use. Further research is needed to understand long-term effects.

Area of Science:

  • Neuroscience
  • Toxicology
  • Anesthesiology

Background:

  • The FDA warns that prolonged exposure to inhaled anesthetics in young children may cause neurological damage, but clinical evidence is limited.
  • Preclinical studies on the neurotoxic potential of common anesthetics like sevoflurane, isoflurane, and desflurane are needed to assess risks.

Approach:

  • A systematic review and meta-analysis of preclinical studies on isoflurane, sevoflurane, and desflurane exposure in young animals was conducted.
  • Data on neurodegeneration (Caspase-3, TUNEL) and behavioral outcomes (Morris water maze, Elevated plus maze, Open field, Fear conditioning) were extracted and analyzed.

Key Points:

  • Sevoflurane, isoflurane, and desflurane exposure significantly increased markers of neurodegeneration (Caspase-3, TUNEL).
  • Sevoflurane and isoflurane exposure impaired learning and memory and increased anxiety in animal models.
  • Even single exposure to sevoflurane or isoflurane negatively impacted brain development and behavior.

Conclusions:

  • Preclinical evidence indicates that common inhaled anesthetics, particularly sevoflurane and isoflurane, can cause neurodegeneration and behavioral changes in young animals.
  • These effects, including impaired learning, memory, and increased anxiety, are evident after single exposures.
  • The findings suggest that the use of sevoflurane and isoflurane in young children should be minimized pending further research on long-term impacts.